Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Clin Exp Hypertens ; 38(7): 586-593, 2016.
Article in English | MEDLINE | ID: mdl-27649588

ABSTRACT

Mesenchymal stem cells (MSC) induced neovascularization and improved renal morphology of the stenotic kidney in 2 kidneys-1 clip (2K-1C) model of renovascular hypertension. The present study evaluated the effects of MSC in the contralateral hypertensive kidney. Three weeks after left renal artery occlusion, MSC were injected into the tail vein of the 2K-1C rats. Renal function and morphology were analyzed in both kidneys. Labeled MSC were found in stenotic and contralateral kidneys. Hypertensive 2K-1C animals presented increased circulating levels of Angiotensin II (Ang II) and renin. MSC prevented the progressive increase of blood pressure and reduced circulating Ang II and renin levels. Stenotic kidney showed reduced renal plasma flow (RPF) and glomerular filtration rate (GFR), whereas the contralateral kidney had a tendency (p > 0.5) of reduction in GFR in spite of unchanged RPF. MSC treatment caused an improvement in GFR with no effect of on RPF in the stenotic kidney. Contralateral kidney showed increased diuresis and natriuresis that were even higher in MSC-treated animals, indicating that cell treatment improved the capacity of the contralateral kidney to excrete sodium. Contralateral kidney expressed higher levels of inflammatory cytokines (IL-6, TNF-α) and signs of fibrosis, which were attenuated by MSC treatment. MSC treatment improved the stenotic kidney function, and it was also beneficial to the contralateral hypertensive kidney because it improved the morphology and preserved its capacity to excrete sodium.


Subject(s)
Angiotensin II/blood , Hypertension, Renovascular , Kidney , Mesenchymal Stem Cell Transplantation/methods , Mesenchymal Stem Cells/metabolism , Renin/blood , Animals , Blood Pressure/physiology , Hypertension, Renovascular/physiopathology , Hypertension, Renovascular/prevention & control , Interleukin-6/metabolism , Kidney/pathology , Kidney/physiopathology , Kidney Function Tests/methods , Male , Rats , Renal Artery/surgery , Renal Elimination/physiology , Sodium/metabolism , Treatment Outcome , Tumor Necrosis Factor-alpha/metabolism
2.
PLoS One ; 11(2): e0150096, 2016.
Article in English | MEDLINE | ID: mdl-26914675

ABSTRACT

Pregnancy is characterized by maternal systemic and intrarenal vasodilation, leading to increases in the renal plasma flow (RPF) and glomerular filtration rate (GFR). These responses are mainly mediated by nitric oxide (NO) and relaxin. The impact of cigarette smoking on the maternal adaptations to pregnancy is unclear. Here we evaluated the effects of chronic exposure to nicotine on systemic and intrarenal parameters in virgin (V) and 14-day pregnant (P) Wistar rats. V and P groups received saline or nicotine (6 mg·kg(-1)·day(-1)) respectively, via osmotic minipumps for 28 days, starting 14 days before pregnancy induction. Nicotine induced a 10% increase in blood pressure in the V group and minimized the characteristic pregnancy-induced hypotension. Renal sympathetic nerve activity (rSNA) and baroreflex sensitivity were impaired by nicotine mainly in the P group, indicating that the effect of nicotine on blood pressure was not mediated by nervous system stimulation. Nicotine had no effect on GFR in the V rats but reduced GFR of the P group by 30%. Renal expression of sodium and water transporters was downregulated by nicotine, resulting in increased fractional sodium excretion mainly in the P group, suggesting that nicotine compromised the sodium and water retention required for normal gestation. There was a reduction in the expression of inducible NO synthase (iNOS) in both the kidney tissue and renal artery, as well as in the expression of the relaxin receptor (LGR7). These results clearly show that nicotine induced deleterious effects in both virgin and pregnant animals, and abolished the maternal capacity to adapt to pregnancy.


Subject(s)
Adaptation, Physiological/drug effects , Environmental Exposure/adverse effects , Glomerular Filtration Rate/drug effects , Nicotine/adverse effects , Renal Plasma Flow/drug effects , Vasodilation/drug effects , Animals , Baroreflex/drug effects , Blood Pressure/drug effects , Female , Kidney/physiopathology , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/biosynthesis , Pregnancy , Rats , Rats, Wistar , Receptors, G-Protein-Coupled/biosynthesis , Receptors, Peptide/biosynthesis , Relaxin/metabolism , Sympathetic Nervous System/physiology , Vasodilation/physiology
3.
Vasc Endovascular Surg ; 48(3): 207-16, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24399130

ABSTRACT

Angiogenic therapies for critical limb ischemia were tested in a mouse model. The mice were anesthetized and their femoral arteries were ligated. The animals were treated with bone marrow mononuclear cells (BMMCs) alone, BMMCs combined with plasmid vector encoding granulocyte macrophage colony-stimulating factor (GM-CSF), received no treatment, or no intervention (controls). The degree of ischemia was monitored for 4 weeks using a visual scale. Muscle atrophy and strength were assessed at 4 weeks postoperatively; the mice were then killed. In treated animals, total necrosis of the limb was not found, the weight of the gastrocnemius and quadriceps muscles was significantly higher, functional ability and tissue regeneration were significantly increased, and muscle impairment and adipocyte presence were significantly reduced compared with untreated animals. At inducing angiogenesis, the BMMCs alone was more effective than BMMCs combined with plasmid vector encoding GM-CSF. Treated animals showed increased angiogenesis compared with ischemic untreated ones.


Subject(s)
Bone Marrow Transplantation , Genetic Therapy , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Ischemia/therapy , Neovascularization, Physiologic , Quadriceps Muscle/blood supply , Animals , Cells, Cultured , Critical Illness , Disease Models, Animal , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Hindlimb , Ischemia/genetics , Ischemia/metabolism , Ischemia/physiopathology , Male , Mice , Mice, Inbred BALB C , Muscle Strength , Muscular Atrophy/pathology , Muscular Atrophy/physiopathology , Muscular Atrophy/therapy , Necrosis , Quadriceps Muscle/pathology , Quadriceps Muscle/physiopathology , Time Factors , Transfection
4.
Am J Physiol Renal Physiol ; 304(2): F189-97, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23136005

ABSTRACT

The exposure of the fetus to a hyperglycemic environment promotes the development of hypertension and renal dysfunction in the offspring at adult age. We evaluated the role of renal nerves in the hypertension and renal changes seen in offspring of diabetic rats. Diabetes was induced in female Wistar rats (streptozotocin, 60 mg/kg ip) before mating. Male offspring from control and diabetic dams were studied at an age of 3 mo. Systolic blood pressure measured by tail cuff was increased in offspring of diabetic dams (146 ± 1.6 mmHg, n = 19, compared with 117 ± 1.4 mmHg, n = 18, in controls). Renal function, baseline renal sympathetic nerve activity (rSNA), and arterial baroreceptor control of rSNA were analyzed in anesthetized animals. Glomerular filtration rate, fractional sodium excretion, and urine flow were significantly reduced in offspring of diabetic dams. Two weeks after renal denervation, blood pressure and renal function in offspring from diabetic dams were similar to control, suggesting that renal nerves contribute to sodium retention in offspring from diabetic dams. Moreover, basal rSNA was increased in offspring from diabetic dams, and baroreceptor control of rSNA was impaired, with blunted responses to infusion of nitroprusside and phenylephrine. Thus, data from this study indicate that in offspring from diabetic mothers, renal nerves have a clear role in the etiology of hypertension; however, other factors may also contribute to this condition.


Subject(s)
Adrenergic Fibers/physiology , Diabetes Mellitus, Experimental/complications , Hypertension/etiology , Kidney Diseases/etiology , Kidney/innervation , Animals , Blood Pressure , Female , Kidney/physiopathology , Male , Pregnancy , Prenatal Exposure Delayed Effects , Pressoreceptors/physiology , Rats , Rats, Wistar
5.
Can J Physiol Pharmacol ; 90(2): 201-8, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22309003

ABSTRACT

The birdseed Phalaris canariensis (Pc) is popularly used as an antihypertensive agent. The aqueous extract of Pc (AEPc) was administered in adult normotensive Wistar rats and spontaneously hypertensive rats (SHR) and in prehypertensive young SHR (SHR(Y), 3 weeks old). Animals received AEPc (400 mg·kg(-1)·day(-1), by gavage) for 30 days, then groups were divided into 2 subgroups: one was treated for another 30 days and the other received water instead of AEPc for 30 days. AEPc reduced systolic blood pressure (SBP) in both adult groups; however, treatment interruption was followed by a gradual return of the SBP to baseline levels. SHR(Y) became hypertensive 30 days after weaning. AEPc minimized the increase in SBP in SHR(Y), but blood pressure rose to levels similar to those in the untreated group with treatment interruption. There were no changes in renal function, diuresis, or Na(+) excretion. Pc is rich in tryptophan, and the inhibition of the metabolism of tryptophan to kynurenine, a potential vasodilator factor, prevented the blood pressure reducing effect of AEPc. Moreover, AEPc significantly reduced sympathoexcitation. Data indicate that the metabolic derivative of tryptophan, kynurenine, may be a mediator of the volume-independent antihypertensive effect of Pc, which was at least in part mediated by suppression of the sympathetic tonus.


Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Hypertension/drug therapy , Phalaris , Plant Extracts/pharmacology , Prehypertension/drug therapy , Animals , Antihypertensive Agents/isolation & purification , Antihypertensive Agents/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Hypertension/metabolism , Hypertension/physiopathology , Kynurenine/metabolism , Male , Phalaris/chemistry , Plant Extracts/isolation & purification , Plant Extracts/metabolism , Prehypertension/metabolism , Prehypertension/physiopathology , Rats , Rats, Inbred SHR , Rats, Wistar , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/physiopathology , Time Factors , Tryptophan/metabolism
6.
Regul Pept ; 162(1-3): 61-7, 2010 Jun 08.
Article in English | MEDLINE | ID: mdl-20346375

ABSTRACT

Sucrose-fed rats, a model of metabolic syndrome, are characterized by insulin resistance, obesity, hypertension, and high plasma levels of triacylglycerols and angiotensin II (Ang II). However, whether tissue renin-angiotensin system (RAS) is altered in metabolic syndrome is unclear. To study this issue, food ad libitum and water (C) or 20% sucrose solution (SC) were given to adult male Wistar rats, for 30 days. Body weight (BW), blood pressure (BP), epididymal adipose tissue (EPI) mass, rate of in vivo fatty acid (FA) synthesis in EPI, circulating glucose, insulin, leptin, angiotensins I and II, triacylglycerols, and plasma renin (PRA) and angiotensin-converting enzyme (ACE) activities were evaluated. In kidneys and EPI, gene and protein expression of type 1 (AT(1)) and 2 (AT(2)) Ang II receptors, ACE, angiotensinogen (AGT) as well as protein expression of angiotensin-converting enzyme 2 (ACE2) were determined. In both tissues, Ang I, Ang II and Ang-(1-7) contents were also measured by HPLC. In SC rats higher BP, EPI mass, circulating triacylglycerols, insulin, leptin, PRA and, Ang II were found. In EPI, the rate of in vivo FA synthesis was associated with increased Ang-(1-7), protein expression of AT(1) and AT(2) receptors, ACE2, AGT, and gene expression of AGT although a reduction in ACE activity and in adipose Ang I and Ang II contents was observed. In kidneys, AT(1) and AT(2), ACE and AGT gene and protein expression as well as protein expression of ACE2 were unaltered while Ang II, Ang-(1-7) and ACE activity increased. These RAS component changes seem to be tissue specific and possibly are related to enhancement of FA synthesis, EPI mass and hypertension.


Subject(s)
Adipose Tissue/metabolism , Angiotensin I/metabolism , Peptide Fragments/metabolism , Peptidyl-Dipeptidase A/metabolism , Sucrose/administration & dosage , Adipose Tissue/enzymology , Angiotensin-Converting Enzyme 2 , Animals , Base Sequence , Blood Glucose/analysis , Blotting, Western , Chromatography, High Pressure Liquid , DNA Primers , Male , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction
7.
J Gene Med ; 12(3): 310-9, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20077434

ABSTRACT

BACKGROUND: Vascular endothelial growth factor (VEGF) has mostly been tested to treat ischemic diseases, although the outcomes obtained are not satisfactory. Our hypothesis is that the local transient expression of VEGF and stem cell mobilizer granulocyte colony-stimulating factor (G-CSF) genes in ischemic limbs can complement their activities and be more efficient for limb recovery. METHODS: Limb ischemia was surgically induced in mice and 50 microg of VEGF and/or G-CSF genes were locally transferred by electroporation. After 3-4 weeks, evidence of necrosis by visual inspection, capillary density, muscle mass, muscle force and hematopoietic cell mobilization were evaluated. RESULTS: After 4 weeks, 70% and 90% of the animals of the ischemic group (IG) and VEGF-treated group (VG), respectively, presented limb necrosis, in contrast to only 10% observed in the group of mice treated with both VEGF and G-CSF genes (VGG). Recovery of muscle mass and muscle force was higher than 60% in the VGG compared to the non-ischemic group. The mobilization of Sca1+ cells and neutrophils was also higher in the VGG, which may explain the lower level of necrosis observed in this group (22%, in contrast to 70% in the IG). Capillary density and degree of fibrosis were determined in weeks 3 and 4, and also showed a clear benefit as a result of the use of the G-CSF and VEGF genes together. CONCLUSIONS: Gene therapy using VEGF and G-CSF demonstrated a synergistic effect promoting vessel and tissue repair in mouse hind limb ischemia.


Subject(s)
Extremities/blood supply , Genetic Therapy/methods , Granulocyte Colony-Stimulating Factor/genetics , Ischemia/therapy , Peripheral Vascular Diseases/therapy , Vascular Endothelial Growth Factor A/genetics , Animals , Ischemia/blood , Ischemia/etiology , Male , Mice , Mice, Inbred BALB C , Muscle, Skeletal/blood supply , Muscle, Skeletal/physiology , Neovascularization, Physiologic/genetics , Peripheral Vascular Diseases/complications , Regeneration/genetics
8.
Hum Exp Toxicol ; 29(7): 593-9, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20053703

ABSTRACT

The aim of this study was to investigate, through the single-cell gel (comet) assay, whether vitamin C is able to protect against renovascular hypertension-induced genotoxicity in multiple organs. A total of 32 male Wistar rats were divided into four groups: negative control (n = 6); animals treated with vitamin C (n = 6); hypertensive rats (n = 10) and hypertensive rats and treated with vitamin C (n = 10). Hypertension was induced as a result of partial obstruction of the left renal artery by means of a silver clip during 6 weeks. Vitamin C was administered at 150 mg/kg during 7 consecutive days before the end of the experimental period. The results showed that vitamin C was able to protect blood cells against hypertension-induced genotoxicity. Brain, liver and heart cells were also protected by vitamin C following hypertension-induced genotoxic damage. Regarding blood pressure, vitamin C reduced the hypertensive state. In conclusion, our results suggest that vitamin C can prevent hypertension-induced DNA damage in blood, liver, brain and heart cells as well as to normalize the blood pressure of rats.


Subject(s)
Antioxidants/pharmacology , Ascorbic Acid/pharmacology , DNA Damage/drug effects , Hypertension, Renovascular/pathology , Oxidative Stress/drug effects , Analysis of Variance , Animals , Brain/drug effects , Brain/pathology , Comet Assay , Hypertension, Renovascular/drug therapy , Hypertension, Renovascular/prevention & control , Liver/drug effects , Liver/pathology , Male , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Random Allocation , Rats , Rats, Wistar , Reactive Oxygen Species/adverse effects , Statistics, Nonparametric
9.
J Comp Neurol ; 518(5): 567-85, 2010 Mar 01.
Article in English | MEDLINE | ID: mdl-20034060

ABSTRACT

An imbalance of excitatory and inhibitory functions has been shown to contribute to numerous pathological disorders. Accumulating evidence supports the idea that a change in hypothalamic gamma-aminobutyric acid (GABA)-ergic inhibitory and glutamatergic excitatory synaptic functions contributes to exacerbated neurohumoral drive in prevalent cardiovascular disorders, including hypertension. However, the precise underlying mechanisms and neuronal substrates are still not fully elucidated. In the present study, we combined quantitative immunohistochemistry with neuronal tract tracing to determine whether plastic remodeling of afferent GABAergic and glutamatergic inputs into identified RVLM-projecting neurons of the hypothalamic paraventricular nucleus (PVN-RVLM) contributes to an imbalanced excitatory/inhibitory function in renovascular hypertensive rats (RVH). Our results indicate that both GABAergic and glutamatergic innervation densities increased in oxytocin-positive, PVN-RVLM (OT-PVN-RVLM) neurons in RVH rats. Despite this concomitant increase, time-dependent and compartment-specific differences in the reorganization of these inputs resulted in an altered balance of excitatory/inhibitory inputs in somatic and dendritic compartments. A net predominance of excitatory over inhibitory inputs was found in OT-PVN-RVLM proximal dendrites. Our results indicate that, along with previously described changes in neurotransmitter release probability and postsynaptic receptor function, remodeling of GABAergic and glutamatergic afferent inputs contributes as an underlying mechanism to the altered excitatory/inhibitory balance in the PVN of hypertensive rats.


Subject(s)
Glutamic Acid/metabolism , Hypertension, Renovascular/metabolism , Medulla Oblongata/metabolism , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Biomarkers/metabolism , Cardiovascular System/physiopathology , Dendrites/metabolism , Dendrites/ultrastructure , Disease Models, Animal , Excitatory Postsynaptic Potentials/physiology , Glutamate Decarboxylase/metabolism , Hypertension, Renovascular/physiopathology , Immunohistochemistry , Inhibitory Postsynaptic Potentials/physiology , Kidney/physiopathology , Male , Medulla Oblongata/cytology , Neural Pathways/cytology , Neural Pathways/metabolism , Neurons/cytology , Oxytocin/metabolism , Paraventricular Hypothalamic Nucleus/cytology , Rats , Rats, Wistar , Reticular Formation/cytology , Reticular Formation/metabolism , Synaptic Transmission/physiology , Vesicular Glutamate Transport Protein 2/metabolism
10.
Auton Neurosci ; 126-127: 156-62, 2006 Jun 30.
Article in English | MEDLINE | ID: mdl-16603419

ABSTRACT

Previous studies have shown that pharmacological stimulation of a region denominated caudal pressor area (CPA), located in the caudal end of the ventrolateral medulla, induces increases in arterial blood pressure (BP). The aim of this study was to compare the responses on renal sympathetic nerve activity (rSNA) and BP responses mediated by stimulation of CPA or rostral ventrolateral medulla (RVLM), in intact or sino-aortic barodenervated rats. Male Wistar rats (300-350 g, n=15) were anesthetized (urethane 1.2 to 1.4 g/kg, i.v.) and artificially ventilated. The mean arterial pressure (MAP) and rSNA were measured during bilateral glutamate microinjection (10 nmo/100 nl) into the CPA or into the RVLM. Glutamatergic stimulation of the RVLM increased MAP (46+/-7 mm Hg) and rSNA (82+/-21%); during CPA stimulation, MAP and rSNA increased 60+/-7 mm Hg and 93+/-9%, respectively. However, despite the similarity of responses mediated by both regions, the duration of rSNA and blood pressure responses mediated by the CPA were significantly longer than the duration of the responses mediated by the RVLM. After barodenervation, there was an increase in the time-course and magnitude of sympathetic response only in response to RVLM stimulation but not in response to CPA. The results suggest a differential baroreceptor modulation on rSNA mediated by the ventrolateral medulla neurons. Glutamatergic activation of CPA neurons can cause large increases in the rSNA and BP with a weaker baroreceptor modulation when compared to responses mediated by the RVLM neurons.


Subject(s)
Baroreflex/physiology , Medulla Oblongata/cytology , Neurons/physiology , Pressoreceptors/physiology , Analysis of Variance , Animals , Baroreflex/drug effects , Blood Pressure/drug effects , Blood Pressure/physiology , Glutamic Acid/pharmacology , Kidney/innervation , Male , Medulla Oblongata/physiology , Microinjections , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/drug effects , Pressoreceptors/drug effects , Pressoreceptors/radiation effects , Rats , Rats, Wistar , Sympathetic Nervous System/physiology , Time Factors
11.
J Steroid Biochem Mol Biol ; 93(1): 43-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15748831

ABSTRACT

The aim of this study was to analyze the cardiovascular effects of chronic stanozolol administration in male rats. The rats were randomly assigned to one of three groups: (1) control (n=12), (2) chronic treatment with low dose of stanozolol (LD, n=18, 5 mg/kgweek) and; (3) treatment with high dose of stanozolol (HD, n=28, 20 mg/kgweek). Mean arterial pressure (MAP) was higher in both HD (128+/-2.2 mmHg) and LD (126+/-2.5 mmHg) than control (116+/-2 mmHg). The LD group showed an increase in cardiac output (control 121+/-2.5, LD 154+/-5.9 ml/min), whereas in the HD group total peripheral resistance increased (control 1.03+/-0.07, HD 1.26+/-0.07 mmHg/ml/min). Acute sympathetic blockade caused a similar decrease in MAP in all groups. In conscious rats, the baroreflex index for bradycardia (control -3.7+/-0.4, LD -2.0+/-0.1 beat/mmHg) and tachycardia (control -3.6+/-0.3, LD -4.7+/-0.2 beat/mmHg) responses changed only in the LD group. Cardiac hypertrophy was observed in both treated groups (P<0.05). In conclusion, hypertension with differential hemodynamic changes and alterations in the reflex control in heart rate is seen at different stanozolol doses, which may be important variables in the cardiovascular effects of anabolic steroids.


Subject(s)
Anabolic Agents/pharmacology , Baroreflex/drug effects , Cardiovascular System/drug effects , Stanozolol/pharmacology , Sympathetic Nervous System/drug effects , Anabolic Agents/administration & dosage , Animals , Blood Pressure/drug effects , Body Weight/drug effects , Bradycardia , Cardiac Output/drug effects , Cardiomegaly/chemically induced , Cardiotonic Agents/pharmacology , Consciousness , Drug Administration Schedule , Ganglionic Blockers/pharmacology , Hexamethonium/pharmacology , Injections, Subcutaneous , Male , Nitroprusside/pharmacology , Organ Size/drug effects , Phenylephrine/pharmacology , Rats , Rats, Wistar , Stanozolol/administration & dosage , Tachycardia , Testosterone/blood , Vascular Resistance/drug effects , Vasodilator Agents/pharmacology
12.
Auton Neurosci ; 98(1-2): 51-4, 2002 Jun 28.
Article in English | MEDLINE | ID: mdl-12144040

ABSTRACT

The aim of the present study was to analyse the haemodynamic effects induced by the hypothalamic disconnection (HD) caudal or rostral to the paraventricular nucleus of the hypothalamus (PVN). Mean arterial pressure (MAP), hindlimb, renal and mesenteric blood flow and vascular conductance (HVC, RVC and MVC, respectively) were measured in urethane (1.2 g/kg, i.v.) anesthetized rats for 60 min after disconnection. HD caudal to the PVN was performed with a double-edged microknife of bayonet shape (R = 1 mm, H= 2 mm) stereotaxically placed, lowered 2.8 mm caudal to the bregma along the midline. The cut was achieved by rotating the microknife 90 degrees right and 90 degrees left. HD rostral to the PVN was performed with the knife placed 0.8 mm caudal to the bregma. Thirty minutes after the hypothalamic disconnection caudal (HD-C), a decrease in MAP was observed (- 14 +/- 3 mm Hg), reaching a 60-min decrease of 30 +/- 3 mm Hg. Hindlimb conductance increased 10 min after HD (156 +/- 14%) and remained elevated throughout the experimental period. On the contrary, we observed a transitory renal vasoconstriction (82 +/- 9%, < or = 20 min) and a late mesenteric vasodilation, starting at 30 min (108 +/- 4%) and reaching 138 +/- 6% at 60 min. In rats with HD rostral to the PVN, we only observed minor changes in the cardiovascular parameters. In the MAP, there was a slight decrease 60 min after the hypothalamic disconnection rostral (HD-R) (-9 +/- 4 mm Hg). There were no significant changes in HVC. RVC and MVC were increased 60 min after the HD-R (116 +/- 12% and 124 +/- 11%, respectively). These results suggest that vasodilation in the hindlimb and in the mesenteric bed could contribute to the observed decrease in MAP in HD caudal to PVN rats.


Subject(s)
Hemodynamics/physiology , Hypothalamus/physiology , Animals , Blood Pressure/physiology , Denervation , Hindlimb/blood supply , Male , Paraventricular Hypothalamic Nucleus/physiology , Rats , Rats, Wistar , Regional Blood Flow , Renal Circulation/physiology , Splanchnic Circulation/physiology , Vasoconstriction/physiology , Vasodilation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...